Researcher.Life Logo

Pharmacopsychiatry : Impact Factor & More

eISSN: 1439-0795pISSN: 0176-3679

Key Metrics

CiteScore
8.5
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Pharmacology (medical)
SNIP
1.71
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Pharmacopsychiatry

Pharmacopsychiatry Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher GEORG THIEME VERLAG KG
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1984
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Pharmacopsychiatry ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Pharmacopsychiatry

Rates of Hypoprolactinemia in Bipolar Patients Receiving Once-monthly Long-acting Injectable Aripiprazole.
  • 7 May 2026
  • Pharmacopsychiatry
Great Expectations, Limited Evidence: The Emerging Role of Artificial Intelligence in Pharmacopsychiatry.
  • 1 May 2026
  • Pharmacopsychiatry
Artificial Intelligence in Drug Discovery and Development: Raising Quality per Decision.
  • 1 May 2026
  • Pharmacopsychiatry
Clinical and Neurobiological Findings in a Patient With Unipolar Depressive 48-hour-ultrarapid-cycling.
  • 29 Apr 2026
  • Pharmacopsychiatry
Utility of Antidepressant Randomized Controlled Trials for Regular Treatment.
  • 21 Apr 2026
  • Pharmacopsychiatry
Antidepressant Prescribing Patterns At Initial Visits for Patients With Mild Depression: A Retrospective Study.
  • 8 Apr 2026
  • Pharmacopsychiatry
Rates of Hypoprolactinemia in Bipolar Patients Receiving Once-monthly Long-acting Injectable Aripiprazole.
  • 7 May 2026
  • Pharmacopsychiatry
Great Expectations, Limited Evidence: The Emerging Role of Artificial Intelligence in Pharmacopsychiatry.
  • 1 May 2026
  • Pharmacopsychiatry
Artificial Intelligence in Drug Discovery and Development: Raising Quality per Decision.
  • 1 May 2026
  • Pharmacopsychiatry
Clinical and Neurobiological Findings in a Patient With Unipolar Depressive 48-hour-ultrarapid-cycling.
  • 29 Apr 2026
  • Pharmacopsychiatry
Utility of Antidepressant Randomized Controlled Trials for Regular Treatment.
  • 21 Apr 2026
  • Pharmacopsychiatry
Antidepressant Prescribing Patterns At Initial Visits for Patients With Mild Depression: A Retrospective Study.
  • 8 Apr 2026
  • Pharmacopsychiatry

FAQs on Pharmacopsychiatry